Jasper Ridge Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,038
Closed -$892K 67
2017
Q3
$892K Buy
10,038
+90
+0.9% +$6.85K 0.04% 51
2017
Q2
$721K Buy
9,948
+96
+1% +$6.45K 0.04% 57
2017
Q1
$642K Sell
9,852
-2,141
-18% -$135K 0.04% 63
2016
Q4
$751K Buy
+11,993
New +$732K 0.05% 61
2013
Q3
Sell
-4,888
Closed -$202K 112
2013
Q2
$202K Buy
+4,888
New +$214K 0.01% 109

Other funds holding ABBV

Jasper Ridge Partners's ABBV Position: Q4 2017 in Review

Jasper Ridge Partners sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 10,038 shares — an estimated $892K sold.

Jasper Ridge Partners first reported a position in ABBV in Q2 2013 and held it in 5 quarters. The position peaked at $892K in Q3 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Jasper Ridge Partners reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
  • Jasper Ridge Partners sold 10,038 AbbVie shares in Q4 2017, an estimated $892K.
  • Jasper Ridge Partners first reported a position in AbbVie in Q2 2013 and held it in 5 quarters.
  • Jasper Ridge Partners's AbbVie position peaked at $892K in Q3 2017.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Jasper Ridge Partners's 13F filing for Q4 2017, filed 14 Feb 2018.